The K101P and K103R/V179D mutations in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nonnucleoside reverse transcriptase inhibitors.

The K101P and K103R/V179D mutations in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nonnucleoside reverse transcriptase inhibitors.

Item
http://www.wikidata.org/entity/Q41967065
Current perspectives on HIV-1 antiretroviral drug resistanceComparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis.Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance.Bayesian network analyses of resistance pathways against efavirenz and nevirapine.Improving HIV proteome annotation: new features of BioAfrica HIV Proteomics Resource.HIV-1 drug resistance mutations: an updated framework for the second decade of HAARTAnalysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq).Nonpolymorphic human immunodeficiency virus type 1 protease and reverse transcriptase treatment-selected mutations.Use of tissue culture cell lines to evaluate HIV antiviral resistance.Mining protein dynamics from sets of crystal structures using "consensus structures".Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing.The frequency of HIV-I drug resistance mutations among treatment-naive individuals at a tertiary care centre in south India.HIV Reverse Transcriptase and Protease Genes Variability Can Be a Biomarker Associated with HIV and Hepatitis B or C Coinfection.
P2860

The K101P and K103R/V179D mutations in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nonnucleoside reverse transcriptase inhibitors.

Item
http://www.wikidata.org/entity/Q41967065
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The K101P and K103R/V179D muta ...... erse transcriptase inhibitors.
@en
type
label
The K101P and K103R/V179D muta ...... erse transcriptase inhibitors.
@en
prefLabel
The K101P and K103R/V179D muta ...... erse transcriptase inhibitors.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
The K101P and K103R/V179D muta ...... erse transcriptase inhibitors.
@en
P2093
P2860
P304
P31
P356
10.1128/AAC.50.1.351-354.2006
P407
P433
P478
P50
P577
P698
P932